Viewing StudyNCT02187991



Ignite Creation Date: 2024-05-06 @ 3:01 AM
Last Modification Date: 2024-10-26 @ 11:27 AM
Study NCT ID: NCT02187991
Status: COMPLETED
Last Update Posted: 2023-08-14
First Post: 2014-07-06

Brief Title: Study to Compare Alisertib With Paclitaxel vs Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer
Sponsor: US Oncology Research
Organization: US Oncology Research

Conditions & Keywords Data

Conditions:
Name
Malignant Neoplasm of Breast
Breast Cancer
Breast Carcinoma
Breast Tumors
Keywords:
Name View
paclitaxel View
metastatic breast cancer View
Human Epidermal Growth Factor Receptor 2-negative HER2- breast cancer View
Estrogen Receptor-positive ER breast cancer View
Triple Negative breast cancer View
alisertib View